Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.
1dOpinion
MedPage Today on MSNThe 23andMe Bankruptcy: A Warning Shot for Genetic Privacy in the Age of AIThere is a federal law, the Genetic Information Nondiscrimination Act (GINA) of 2008, that is supposed to protect Americans ...
The first clinical trial of a generative AI therapy bot suggests it was as effective as human therapy for people with ...
Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...
The financial collapse of personal genomics giant 23andMe raises an urgent question: What happens to your most intimate data when the company holding it goes ...
Genetics testing company 23andMe has filed for Chapter 11 bankruptcy—and the possible impact of this move on data privacy has ...
Whether the Sei Foundation buys 23andMe, or not, the genetic data company’s bankruptcy shows the perils of centralized data ...
STAT reporters discuss the layoffs and reorganization of HHS, data privacy concerns following 23andMe's bankruptcy filing, ...
The start of 23andMe Holding Co.'s closely watched bankruptcy proceedings offers customers a troubling reminder of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results